510(k) · Cleared
ClearedStarchmark Breast Tissue Marker; Starchmark Ultracor Breast Tissue Marker
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Senorx, Inc. · NEU Marker, Radiographic, Implantable
Cleared on Jun 27, 2013 as substantially equivalent to K081085 (Senorx, Inc., 2008) after a 21-day review. Its family tree reaches back 2 generations to 2003. 1 later device descends from it.
- Decided
- Jun 27, 2013
- Review
- 21 days
- Class
- Class II
- Product code
- NEU
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 2 generations to K031938 (2003). 1 later device descends from it, 1 citing it directly.
- Root · 2 generations backK031938 Gel Mark Iii Biopsy Site MarkerSenorx, Inc. · 2003
- 1 generation backK081085 Starchmark Biopsy Site Marker, Model Stmkec-10GSS, Stmkec-10GTR…Senorx, Inc. · 2008
- This deviceK131654 Starchmark Breast Tissue Marker; Starchmark Ultracor Breast Tissue…Senorx, Inc. · 2013
- Descendant · cites it directly · 0 of its ownK153189 Beacon Tissue Marker (SE)Scion Medical Technologies, LLC · 2015
Most influential descendants
Showing 1 of 1 · See all- K153189Beacon Tissue Marker (SE)Scion Medical Technologies, LLC · 2015 · cites it directly0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −2 | K031938 | Gel Mark Iii Biopsy Site Marker | Senorx, Inc. | 2003 | — |
| −1 | K081085 | Starchmark Biopsy Site Marker, Model Stmkec-10GSS, Stmkec-10GTR, Stmkmt-11GS | Senorx, Inc. | 2008 | — |
| 0 (this device) | K131654 | Starchmark Breast Tissue Marker; Starchmark Ultracor Breast Tissue Marker | Senorx, Inc. | 2013 | — |
| +1 | K153189 | Beacon Tissue Marker (SE) | Scion Medical Technologies, LLC | 2015 | — |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2015 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in NEU? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new NEU device
- #1 K240042 MOLLI 2 Systemscore 14.4 · 12 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K081085 | Starchmark Biopsy Site Marker, Model Stmkec-10GSS, Stmkec-10GTR, Stmkmt-11GSSummary page 1…Product Code NEU) Review Panel: General & Plastic Surgery Regulation Number: 21 CFR 878.4300 (Implantable Clip) 3. Predicate Device: StarchMark® Breast Tissue Marker (K081085; cleared August 1, 2008) 4. Summary of Change: A statement régarding allergic reactions was moved from the warnings section to… | 2008 |
What descends from it? (1)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K153189 | Beacon Tissue Marker (SE) | 2015 | 0 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 10 years and passes through 1 company; a new generation was cleared every 4.9 years on median.
- None of the 2 ancestors has a recall.
- Of its descendants, K153189 (Scion Medical Technologies, LLC, 2015) has gone furthest, with 0 descendants of its own.
How does its category compare?
All NEU devicesNEU Marker, Radiographic, Implantable: FDA decisions, review times, recalls and adverse event reports over 20 years. 2013, this device’s year, is highlighted.
FDA decisions per year · NEU
5in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · NEU
99in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · NEU
2in 2025
Class I (1 since 2007) Class II/III not classified
Adverse event reports per year · NEU
411in 2025
MAUDE reports naming product code NEU, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 4 | 94 | 0 | 5 |
| 2008 | 7 | 107 | 0 | 5 |
| 2009 | 4 | 70 | 0 | 30 |
| 2010 | 5 | 69 | 0 | 12 |
| 2011 | 3 | 145 | 1 | 18 |
| 2012 | 3 | 120 | 0 | 54 |
| 2013 | 7 | 49 | 0 | 60 |
| 2014 | 3 | 48 | 0 | 38 |
| 2015 | 7 | 111 | 0 | 120 |
| 2016 | 2 | — | 0 | 56 |
| 2017 | 4 | 115 | 1 | 69 |
| 2018 | 8 | 89 | 0 | 66 |
| 2019 | 5 | 149 | 0 | 58 |
| 2020 | 3 | 169 | 0 | 45 |
| 2021 | 3 | 46 | 0 | 82 |
| 2022 | 2 | — | 1 | 100 |
| 2023 | 4 | 136 | 0 | 142 |
| 2024 | 10 | 267 | 2 (1) | 247 |
| 2025 | 5 | 99 | 2 | 411 |
| 2026 | 1 | — | 2 | — |
What is it indicated for?
The Breast Tissue Marker is intended to radiographically mark breast tissue during a percutaneous breast biopsy procedure.
Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.
https://510kreport.com/device/K131654 · printed Nov 6, 2026
Cite this page
510(k) Report. “K131654: Starchmark Breast Tissue Marker; Starchmark Ultracor Breast Tissue Marker.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K131654
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026